EAST ST. LOUIS – After the makers of Pradaxa settled claims for $650 million three years ago, a Mississippi woman is suing the drug company alleging the prescription medication caused her to develop bleeding that required hospitalization.
Dale Ziegler filed a complaint on Aug. 8 in the U.S. District Court for the Southern District of Illinois against Boehringer Ingelheim Pharmaceuticals Inc., alleging it failed its duty of reasonable care with the design, testing, manufacturing, marketing, and/or labeling of Pradaxa.
Pradaxa-related claims against Boehringer, litigated in multi-district litigation at the Southern District of Illinois, were settled in 2014 for $650 million. According to an article in Aboutlawsuits.com, after the settlement, the pharmaceutical company faced a new round of claims.
According to the complaint, the plaintiff alleges that on April 11, 2016, she was prescribed the defendant's drug Pradaxa. She claims she was later hospitalized for a severe gastrointestinal bleed.
The plaintiff alleges the defendant concealed the defective nature of Pradaxa and failed to provide adequate warnings based on what it knew or should have known about the adverse effects of the drug.
The plaintiff requests a trial by jury and seeks compensation for actual, economic damages, pre- and post-judgment interest, costs of suit and any other relief to which plaintiff may be entitled.
He is represented by John D. Sileo and Casey W. Moll of John D. Sileo in New Orleans.
U.S. District Court for the Southern District of Illinois case number 3:17-cv-00846